Vietnam proposes Pfizer cooperate in COVID-19 drug production

VOV correspondent in the US
Chia sẻ
(VOVWORLD) - Vietnamese Ambassador to the US Ha Kim Ngoc has proposed that Pfizer, one of the world's leading pharmaceutical and biotechnology companies, cooperate with Vietnam in the production of COVID-19 treatment drugs and accelerate efforts to have an effective and safe vaccine for children.

Mr. Ngoc was speaking at a meeting on Friday (local time) between the ASEAN Committee in Washington DC and Stephen Claeys, Senior Director, Trade Policy at Pfizer, on cooperation between ASEAN member states and the US firm.

Ambassador Ngoc appreciated Pfizer's support for Vietnam and requested the company to realise its vaccine supply commitment to the country in 2021 and continue discussing with Vietnamese agencies on vaccine supply for 2022.

Sharing Vietnam's view that Pfizer should build a production facility in Southeast Asia, ambassadors and representatives from several countries including the Philippines and Singapore proposed tripartite cooperation between Pfizer, ASEAN and the US government in pandemic prevention.

They called on Pfizer to continue helping countries coexist with COVID-19 and prepare for future pandemics.

Clayes praised ASEAN countries’ proposals and said Pfizer will implement the signed commitments, including those with Vietnam.

Feedback